学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
CEFEPIME VERSUS CEFOTAXIME IN THE TREATMENT OF LOWER RESPIRATORY-TRACT INFECTIONS
被引:19
作者
:
BARCKOW, D
论文数:
0
引用数:
0
h-index:
0
机构:
Universitätsklinikum Rudolf- Virchow, Standort Charlottenburg, Berlin, 1000
BARCKOW, D
SCHWIGON, CD
论文数:
0
引用数:
0
h-index:
0
机构:
Universitätsklinikum Rudolf- Virchow, Standort Charlottenburg, Berlin, 1000
SCHWIGON, CD
机构
:
[1]
Universitätsklinikum Rudolf- Virchow, Standort Charlottenburg, Berlin, 1000
来源
:
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
|
1993年
/ 32卷
关键词
:
D O I
:
10.1093/jac/32.suppl_B.187
中图分类号
:
R51 [传染病];
学科分类号
:
100401 ;
摘要
:
Patients with lower respiratory tract infection (LRTI) were randomized 2 1 to receive either cefepime 2 g iv bd or cefotaxime 2 g iv tds. Bronchopneumonia alone or associated with another LRTI was diagnosed in 30 of 37 cefepime recipients and in 11 of 18 cefotaxime recipients; other diagnoses included bronchitis, lobar pneumonia and aspiration pneumonia. The mean duration of treatment was 5.9 days in the cefepime group and 5.4 days in the cefotaxime group. There were no significant differences between the two groups with regard to clinical or bacteriological outcome. Treatment was associated with a satisfactory clinical response in 27 (73%) of 37 evaluable cefepime patients and in 10 (56%) of 18 evaluable cefotaxime patients. Treatment resulted in eradication of 33 (89%) of 37 pathogens in the cefepime group, including 13 of 15 strains of Staphylococcus aureus, and of 16 (73%) of 22 pathogens in the cefotaxime group, including eight of ten strains of S. aureus. Two Pseudomonas aerugmosa strains persisted in the cefotaxime group. The sole clinical adverse event reported was a rash in one cefepime patient which did not require discontinuation of treatment. No clinically relevant changes in laboratory test results were attributed to either agent. Cefepime twice daily and cefotaxime three times daily were of comparable safety and efficacy in the treatment of bronchopneumonia and other LRTIs. © 1993 The British Society for Antimicrobial Chemotheraphy.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 8 条
[1]
INVITRO ACTIVITY OF CEFEPIME, A NEW PARENTERAL CEPHALOSPORIN, AGAINST RECENT EUROPEAN BLOOD ISOLATES AND IN COMPARISON WITH PIPERACILLIN TAZOBACTAM
DORNBUSCH, K
论文数:
0
引用数:
0
h-index:
0
机构:
Department of Clinical Microbiology, Karolinska Hospital, Stockholm
DORNBUSCH, K
MORTSELL, E
论文数:
0
引用数:
0
h-index:
0
机构:
Department of Clinical Microbiology, Karolinska Hospital, Stockholm
MORTSELL, E
GORANSSON, E
论文数:
0
引用数:
0
h-index:
0
机构:
Department of Clinical Microbiology, Karolinska Hospital, Stockholm
GORANSSON, E
[J].
CHEMOTHERAPY,
1990,
36
(04)
: 259
-
267
[2]
NEW AND EMERGING ETIOLOGIES FOR COMMUNITY-ACQUIRED PNEUMONIA WITH IMPLICATIONS FOR THERAPY - A PROSPECTIVE MULTICENTER STUDY OF 359 CASES
FANG, GD
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
FANG, GD
FINE, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
FINE, M
ORLOFF, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
ORLOFF, J
ARISUMI, D
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
ARISUMI, D
YU, VL
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
YU, VL
KAPOOR, W
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
KAPOOR, W
GRAYSTON, JT
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
GRAYSTON, JT
WANG, SP
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
WANG, SP
KOHLER, R
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
KOHLER, R
MUDER, RR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
MUDER, RR
YEE, YC
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
YEE, YC
RIHS, JD
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
RIHS, JD
VICKERS, RM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
VICKERS, RM
[J].
MEDICINE,
1990,
69
(05)
: 307
-
316
[3]
ACTIVITY OF CEFEPIME AGAINST CEFTAZIDIME-RESISTANT AND CEFOTAXIME-RESISTANT GRAM-NEGATIVE BACTERIA AND ITS RELATIONSHIP TO BETA-LACTAMASE LEVELS
FUNGTOMC, J
论文数:
0
引用数:
0
h-index:
0
机构:
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
FUNGTOMC, J
DOUGHERTY, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
DOUGHERTY, TJ
DEORIO, FJ
论文数:
0
引用数:
0
h-index:
0
机构:
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
DEORIO, FJ
SIMICHJACOBSON, V
论文数:
0
引用数:
0
h-index:
0
机构:
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
SIMICHJACOBSON, V
KESSLER, RE
论文数:
0
引用数:
0
h-index:
0
机构:
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
KESSLER, RE
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1989,
33
(04)
: 498
-
502
[4]
JONES RN, 1992, DIAGN MICR INFEC DIS, V15, pS3
[5]
COMPARISON OF A NEW CEPHALOSPORIN, BMY 28142, WITH OTHER BROAD-SPECTRUM BETA-LACTAM ANTIBIOTICS
KESSLER, RE
论文数:
0
引用数:
0
h-index:
0
KESSLER, RE
BIES, M
论文数:
0
引用数:
0
h-index:
0
BIES, M
BUCK, RE
论文数:
0
引用数:
0
h-index:
0
BUCK, RE
CHISHOLM, DR
论文数:
0
引用数:
0
h-index:
0
CHISHOLM, DR
PURSIANO, TA
论文数:
0
引用数:
0
h-index:
0
PURSIANO, TA
TSAI, YH
论文数:
0
引用数:
0
h-index:
0
TSAI, YH
MISIEK, M
论文数:
0
引用数:
0
h-index:
0
MISIEK, M
PRICE, KE
论文数:
0
引用数:
0
h-index:
0
PRICE, KE
LEITNER, F
论文数:
0
引用数:
0
h-index:
0
LEITNER, F
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1985,
27
(02)
: 207
-
216
[6]
MARRIE TJ, 1989, REV INFECT DIS, V11, P586
[7]
DEVELOPMENT OF RESISTANCE DURING CEFTAZIDIME AND CEFEPIME THERAPY IN A MURINE PERITONITIS MODEL
PECHERE, JC
论文数:
0
引用数:
0
h-index:
0
机构:
Department de Génétique et Microbiologie, Centre Médical, Univesitaire, CH-1211 Geneva
PECHERE, JC
VLADOIANU, IR
论文数:
0
引用数:
0
h-index:
0
机构:
Department de Génétique et Microbiologie, Centre Médical, Univesitaire, CH-1211 Geneva
VLADOIANU, IR
[J].
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY,
1992,
29
(05)
: 563
-
573
[8]
1990, M7A2 NCCLS NAT COMM
←
1
→
共 8 条
[1]
INVITRO ACTIVITY OF CEFEPIME, A NEW PARENTERAL CEPHALOSPORIN, AGAINST RECENT EUROPEAN BLOOD ISOLATES AND IN COMPARISON WITH PIPERACILLIN TAZOBACTAM
DORNBUSCH, K
论文数:
0
引用数:
0
h-index:
0
机构:
Department of Clinical Microbiology, Karolinska Hospital, Stockholm
DORNBUSCH, K
MORTSELL, E
论文数:
0
引用数:
0
h-index:
0
机构:
Department of Clinical Microbiology, Karolinska Hospital, Stockholm
MORTSELL, E
GORANSSON, E
论文数:
0
引用数:
0
h-index:
0
机构:
Department of Clinical Microbiology, Karolinska Hospital, Stockholm
GORANSSON, E
[J].
CHEMOTHERAPY,
1990,
36
(04)
: 259
-
267
[2]
NEW AND EMERGING ETIOLOGIES FOR COMMUNITY-ACQUIRED PNEUMONIA WITH IMPLICATIONS FOR THERAPY - A PROSPECTIVE MULTICENTER STUDY OF 359 CASES
FANG, GD
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
FANG, GD
FINE, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
FINE, M
ORLOFF, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
ORLOFF, J
ARISUMI, D
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
ARISUMI, D
YU, VL
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
YU, VL
KAPOOR, W
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
KAPOOR, W
GRAYSTON, JT
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
GRAYSTON, JT
WANG, SP
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
WANG, SP
KOHLER, R
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
KOHLER, R
MUDER, RR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
MUDER, RR
YEE, YC
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
YEE, YC
RIHS, JD
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
RIHS, JD
VICKERS, RM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PITTSBURGH, VET ADM MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA
VICKERS, RM
[J].
MEDICINE,
1990,
69
(05)
: 307
-
316
[3]
ACTIVITY OF CEFEPIME AGAINST CEFTAZIDIME-RESISTANT AND CEFOTAXIME-RESISTANT GRAM-NEGATIVE BACTERIA AND ITS RELATIONSHIP TO BETA-LACTAMASE LEVELS
FUNGTOMC, J
论文数:
0
引用数:
0
h-index:
0
机构:
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
FUNGTOMC, J
DOUGHERTY, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
DOUGHERTY, TJ
DEORIO, FJ
论文数:
0
引用数:
0
h-index:
0
机构:
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
DEORIO, FJ
SIMICHJACOBSON, V
论文数:
0
引用数:
0
h-index:
0
机构:
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
SIMICHJACOBSON, V
KESSLER, RE
论文数:
0
引用数:
0
h-index:
0
机构:
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
BRISTOL MYERS CO,DEPT MICROBIOL,DEV PHARMACEUT RES & DEV,WALLINGFORD,CT 06492
KESSLER, RE
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1989,
33
(04)
: 498
-
502
[4]
JONES RN, 1992, DIAGN MICR INFEC DIS, V15, pS3
[5]
COMPARISON OF A NEW CEPHALOSPORIN, BMY 28142, WITH OTHER BROAD-SPECTRUM BETA-LACTAM ANTIBIOTICS
KESSLER, RE
论文数:
0
引用数:
0
h-index:
0
KESSLER, RE
BIES, M
论文数:
0
引用数:
0
h-index:
0
BIES, M
BUCK, RE
论文数:
0
引用数:
0
h-index:
0
BUCK, RE
CHISHOLM, DR
论文数:
0
引用数:
0
h-index:
0
CHISHOLM, DR
PURSIANO, TA
论文数:
0
引用数:
0
h-index:
0
PURSIANO, TA
TSAI, YH
论文数:
0
引用数:
0
h-index:
0
TSAI, YH
MISIEK, M
论文数:
0
引用数:
0
h-index:
0
MISIEK, M
PRICE, KE
论文数:
0
引用数:
0
h-index:
0
PRICE, KE
LEITNER, F
论文数:
0
引用数:
0
h-index:
0
LEITNER, F
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1985,
27
(02)
: 207
-
216
[6]
MARRIE TJ, 1989, REV INFECT DIS, V11, P586
[7]
DEVELOPMENT OF RESISTANCE DURING CEFTAZIDIME AND CEFEPIME THERAPY IN A MURINE PERITONITIS MODEL
PECHERE, JC
论文数:
0
引用数:
0
h-index:
0
机构:
Department de Génétique et Microbiologie, Centre Médical, Univesitaire, CH-1211 Geneva
PECHERE, JC
VLADOIANU, IR
论文数:
0
引用数:
0
h-index:
0
机构:
Department de Génétique et Microbiologie, Centre Médical, Univesitaire, CH-1211 Geneva
VLADOIANU, IR
[J].
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY,
1992,
29
(05)
: 563
-
573
[8]
1990, M7A2 NCCLS NAT COMM
←
1
→